Search clinical trials for: Galantamine 16mg

Total 1097 results

Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.

Completed

Pharmacokinetic Study of KHK7580 in Healthy Adult Volunteers

Healthy Volunteer

China
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Study to Help People Quit Smoking.

Nicotine Dependence

United States
EnnovaBio Australia Pharmaceuticals Pty Ltd

Completed

A First-in-human Single Ascending Dose/Multiple Ascending Dose Study of ENN0403 in Healthy Subjects

Healthy

Australia
The University of Texas Health Science Center,...

Completed

Subarachnoid Hemorrhage Recovery And Galantamine (SAHRANG)

Subarachnoid Hemorrhage

United States
Genor Biopharma Co., Ltd.

Unknown

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Rheumatoid Arthritis

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Recruiting

A Study of HS-20094 in T2DM Participants

Type 2 Diabetes

China
HK inno.N Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil Monotherapy

Essential Hypertension

Korea, Republic of
Linda Van Eldik
National Institute on Aging (NIA); Duke Clinical Research Institute

Completed

MW151-101: First-in-human Study of MW151

Drug Toxicity

United States
Mitsubishi Tanabe Pharma America Inc.

Completed

MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women

Menopause Hot Flashes

United States
HK inno.N Corporation

Completed

A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy

Essential Hypertension

Korea, Republic of
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Recruiting

A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects

Schizophrenia

China
University of Edinburgh
NHS Lothian

Completed

Cardiovascular Effects of Apelin In Healthy Volunteers

Healthy

United Kingdom
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.

Not yet recruiting

A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Samsung Medical Center
Janssen Korea, Ltd., Korea

Completed

Characteristics of Treatment Responders to Galantamine

Dementia

Korea, Republic of
Ludwig-Maximilians - University of Munich

Unknown

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

Alzheimer's Disease

Germany
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH); Massachusetts General Hospital

Completed

Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder

Bipolar Disorder

United States
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
The Alfred

Completed

Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone

Heart Failure | Healthy

Australia
Hangzhou Grand Biologic Pharmaceutical, Inc.
Peking Union Medical College Hospital

Unknown

Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects

Healthy Participants

China
Vaxon Biotech

Completed

Safety Study of Vx006 Vaccine in Solid Tumor Patients

Solid Tumor

Greece
Actavis Inc.

Completed

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions

Healthy

Canada
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

Dementia, Vascular
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

Alzheimer Disease
LG Life Sciences

Completed

Phase III Clinical Study to Evaluate the Efficacy and Safety of the Combination of Lercanidipine/Valsartan in Hypertensive Patients

Hypertension

Korea, Republic of
Tianjin Chasesun Pharmaceutical Co., LTD
Southwest Hospital, China

Recruiting

Efficacy and Safety of Kukoamine B Mesilate in Sepsis Patients

Sepsis

China
Actavis Inc.

Completed

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

Frontotemporal Dementia | Pick Complex
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

Alzheimer Disease
GlaxoSmithKline

Completed

A Comparison of Atorvastatin and Glimepiride Fixed Dose Combination and Atorvastatin and Glimepiride Loose Combination in the Treatment of Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
Otsuka Pharmaceutical Co., Ltd.

Recruiting

A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])

Cardiac Edema (CHF)

Japan
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

Dementia | Alzheimer Disease
Parkinson's Disease and Movement Disorders Center
Ortho-McNeil Neurologics, Inc.

Terminated

Safety Study of Galantamine in Tic Disorders

Tourette's Syndrome | Motor Tic Disorder | Vocal Tic Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

Alzheimer's Disease
Shin Poong Pharmaceutical Co. Ltd.

Completed

Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension

Essential Hypertension

Korea, Republic of
Xian-Janssen Pharmaceutical Ltd.

Completed

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Pharmacokinetics
Bristol-Myers Squibb

Completed

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)

Alzheimer Disease

United States
North Suffolk Mental Health Association
Janssen Medical Affairs

Completed

Galantamine for Cognition in People With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
HK inno.N Corporation

Unknown

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

Essential Hypertension

Korea, Republic of
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

Alzheimer Disease | Vascular Dementia
University of Sao Paulo
University of Nove de Julho; Feinstein Institute for Medical Research

Completed

Galantamine Effects in Patients With Metabolic Syndrome (GALANTA-MS)

Abdominal Obesity Metabolic Syndrome

Brazil
Janssen Pharmaceutica N.V., Belgium

Completed

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

Alzheimer's Disease
Memorial Hospital of Rhode Island
Ortho-McNeil Neurologics, Inc.

Unknown

Galantamine Executive Function in Parkinson's Disease

Parkinson's Disease

United States
Curon Biopharmaceutical (Australia) Co Pty Ltd
Novotech (Australia) Pty Limited

Terminated

A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies

Relapsed Lymphoid Malignancies | Refractory Lymphoid Malignancies

Australia
University of Maryland, Baltimore
Stanley Medical Research Institute; Ortho-McNeil Neurologics, Inc.

Completed

Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Dementia | Alzheimer Disease

3

Subscribe